8:30 am | Welcome | |
| 8:45 am | Introduction - Xavier GIDROL, co-director ITMO Health Technologies | |
| SESSION 1: TRANSLATIONAL APPLICATION OF ORGANOIDS Chair: Xavier GIDROL, co-director ITMO Health Technologies | ||
| 8:50 am | 3D Bioprinting: Current state-of-the-art – Nathalie DUSSERRE, Bordeaux | |
Organ-on-chips and organ crosstalk | ||
| 9:20 am | Bringing microphysiological systems from lab to real-world application – Berend VAN MEER, Leiden, Netherlands | |
| 9:50 am | Translational considerations for liver organoids: from organ on chip to external bioartificial system – Cécile LEGALLAIS, Compiègne | |
| 10:20 am | Building complexity in gut organoid to study innervation – Maxime MAHE, Nantes | |
| 10:50 am | Cardiac and vascular organoids – Jean-Sébastien HULOT, Paris | |
11:20 am | Colon organoid cultures: what tool for a pharmacologist ? – Nathalie VERGNOLLE, Toulouse | |
| 11:50 pm | Break | |
12:00 pm | Forum – Chair: Jean-Luc Galzi, Strasbourg Flash talks on biotech products/tools for research or clinical use: Stem Genomics, Agnès MIERMONT “New tests to assess the genetic integrity of stem cells”. HCS Pharma, Nathalie MAUBON “Biomimesys® 3D technology which is a natural HA-based scaffold to better mimic the tissue environment” Cellink, Pierre-Alexandre LAURENT “3D bioprinting technologies for organoids engineering: tools BIOX and BioInks” Stemcell technologies, Philippe TROPEL “Standardization tools for 3D cell cultures” | |
| 12:30 pm | Break | |
1:45 pm | Flash talks by young scientists | |
Development of three-dimensional cell culture of canine breast tumor - Antonella RAFFO-ROMERO, Lille 3D modeling of the relationship between diabetes and pancreatic cancer - Anastasia PAPOZ, Grenoble Modulating notochordal differentiation of human induced pluripotent stem cells using 3D culture for intervertebral disc regeneration - Nicolas VEDRENNE, Nantes Design of an optimal O2 balanced bioartificial pancreas - Mathilde MOSSER, Nantes Microencapsulation and differentiation of HepaRG cells and human induced pluripotent stem cells (hiPSCs) into hepatocytes for the Bioartificial liver device - Marwa HUSSEIN, Villejuif | ||
| SESSION 2: ARTIFICIAL ORGANS Chair: Christian BOITARD, co-director ITMO Pathophysiology Metabolism Nutrition | ||
| 2:20 pm | Development of an artificial lung, microfluidics contribution – Olaf MERCIER, Le Plessis-Robinson | |
| 2:50 pm | Recent advances in 3D printing for articular tissue engineering – Christian JORGENSEN, Montpellier | |
| 3:20 pm | CARMAT: total artificial heart – Christian LATREMOUILLE, Paris | |
| 3:50 pm | Retina: RPE derived from human embryonic stem cells disposed on human amniotic membrane, an update on the French RP clinical trial – Christelle MONVILLE, Evry | |
4:20 pm | Round Table - Chair: François HIRSCH, Inserm Ethics Committee | |
| 4:50 pm | Conclusion - Franck LETHIMONNIER, co-director ITMO Health Technologies | |